Author: Scott Welch
Pharmaceutical companies that fought drug pricing reforms Congress passed as part of the Inflation Reduction Act are now weighing a legal challenge as the Biden administration sets about implementing the policy. “I don’t think we’ve made any decisions at this time, but it’s certainly something we’re looking into,” Lori Reilly, the Pharmaceutical Research and Manufacturers ...
House lawmakers backed by a wide array of industries think they have a solution to Medicare’s approaching insolvency: moving more care from the hospital to the home. A new bill from Reps. Adrian Smith (R-Neb.) and Debbie Dingell (D-Mich.) that aims to reduce care in hospitals and other health care facilities and increase it in living rooms marks a ...
Having trouble sleeping? Just 30 minutes of moderate aerobic exercise can help improve sleep quality. A researcher at the Johns Hopkins Center for Sleep says it won’t take long to see a benefit. “It’s generally not going to take months or years to see a benefit,” Charlene Gamaldo, medical director of the Johns Hopkins Center for Sleep ...
What does the end of the COVID public health emergency on May 11 mean for health benefits? The expiration of COVID-19 era public health benefits, including COVID-19 coverage mandates for health insurance and the suspension of Medicaid dis-enrollments, means many workers and employers need to reorient themselves in the health care marketplace. Now, the U.S. Department of ...
Starting next year, California will join at least 10 states — including Colorado, Maryland, and Massachusetts — using tax forms to point people toward the lower-cost coverage available through state insurance marketplaces.
The U.S. government aims to publish the final guidance for its Medicare drug price negotiation program in early July and is currently talking to companies about its contents, a top health official said on Wednesday. The guidance will finalize the details of how President Joe Biden’s signature drug pricing reform will be carried out. The ...
A majority of payers are using outcomes-based contracts for drugs, according to a recent analysis from Avalere. The researchers surveyed 46 health plans based in the U.S. and found that 58% had at least one outcomes-based contract in place in the 2022 plan year. More than a third (35%) said they had at least 10 such contracts ...
Assembly Bill 250, sponsored by Assemblywoman Venicia Considine, D-Las Vegas, and Assemblywoman Natha C. Anderson, D-Sparks, would cap the price of certain drugs to rates negotiated by the federal Department of Health and Human Services.
Employee Navigator, the leading benefits administration and HR software solution for insurance brokers and employers, today announced the acquisition of Ease, the leading broker centric HR and benefits software solution for small businesses.
Cash prices for certain hospital services were lower than the average insurance rate in nearly half of the facilities examined in a new study, which could influence rate negotiations between payers and providers.